On the 2nd, Hanmi Group Chairman Song Young-sook delivered a New Year’s address to all executives and employees of the group with the title, ‘Let’s break away from old habits, reorganize our battle lines, and move forward powerfully globally.’
In his New Year’s address posted on the company’s business network that day, Chairman Song said, “I am grateful to the executives and employees who achieved many achievements last year. Like the blue snake that symbolizes wisdom, determination, and flexibility, we are heading toward a new future with creative innovation and challenging spirit.” “Let’s take a powerful step forward,” he encouraged.
Chairman Song went on to praise the domestic and overseas businesses, R&D division, and each affiliate, citing in detail their achievements last year.
In the domestic business, the company emphasized that it had set a record of being No. 1 in domestic outpatient prescription sales for seven consecutive years, and also expressed expectations for preparations for the launch of next-generation improved/combined new drugs that will be developed into the ‘second Rosuzet’.
In the overseas business division, Hanmi Pharmaceutical exported finished products to the Middle East for the first time in its history, and in the R&D division, it mentioned the aggressive development of the obesity treatment pipeline such as ‘efpeglenatide’ and said, “Even amidst the difficulties, Hanmi Pharmaceutical has clearly shown the direction in which it should move.” “It showed,” he said.
Chairman Song said, “The new year of 2025 is an important year in which Hanmi Group must prepare for a new leap forward. Like a wise snake that sheds its skin, is born anew, and grows bigger, Hanmi Group will also break away from its old ways and move forward in earnest to become a global leader. “It must be done,” he emphasized.
Source: www.nextdaily.co.kr
